Quantum BioPharma Ltd. Depreciation Biological Assets
Quantum BioPharma Ltd. (QNTM) reported Depreciation Biological Assets of CAD 131.96 thousand for the 12-month period ending 2019-12-31, per its 40-F/A filed 2020-03-17.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DepreciationBiologicalAssets · last filed 2020-03-17
| Period end | Depreciation Biological Assets 12 month |
|---|---|
| 2019-12-31 | 131.96K CAD 40-F/A · filed 2020-03-17 |